Recent Findings from University of New England Has Provided New Information about Prescription Opioids (Characterizing the demographics of chronic…

Pharma Business Week

Recent Findings from University of New England Has Provided New Information about Prescription Opioids (Characterizing the demographics of chronic pain patients in the state of Maine using the Maine all payer claims database)

By a News Reporter-Staff News Editor at Pharma Business Week -- A new study on Opioids - Prescription Opioids is now available. According to news reporting originating in Biddeford, Maine, by NewsRx journalists, research stated, "Chronic pain is currently a significant health problem in the United States. A comprehensive strategy is needed to increase prevention of chronic pain and to improve care for chronic pain patients."

The news reporters obtained a quote from the research from the University of New England, "However, development of a successful strategy relies, in part, on a better understanding of the demographics and socioeconomics of patients living with chronic pain conditions. The current study was designed to understand the burden of chronic pain in the state of Maine by identifying the prevalence of chronic pain and its relationship with selected demographic and socioeconomic factors in Maine. The Maine All Payer Claims Database (MEAPCD) (2006-2011) was used in the secondary data analysis to assess the demographic characteristics (such as age, sex, insurance type, and county of residence) of chronic pain patients in Maine. Chronic pain patients were identified based on the presence of pre-identified chronic pain-associated ICD-9 code(s) and opioid prescription information. Potential associations between the prevalence of chronic pain and a number of socioeconomic factors were determined by comparisons to Maine Census data. More women in the state were identified as having chronic pain across all counties and all age groups (> 10 years old). Surprisingly, the majority of chronic pain patients were identified based on the diagnostic code criteria and not the opioid prescription criteria. A greater utilization of public health insurance was seen within the chronic pain patients. At the county level, although neither education level nor income were associated with the prevalence of chronic pain, these factors significantly correlated with the usage of public health insurance."

According to the news reporters, the research concluded: "Further detailed characterization of the chronic pain patient population in the state of Maine, using multiple data sources, can help design population-targeted strategies to prevent and manage chronic pain."

For more information on this research see: Characterizing the demographics of chronic pain patients in the state of Maine using the Maine all payer claims database. BMC Public Health, 2018;18():32-43. BMC Public Health can be contacted at: Bmc, Campus, 4 Crinan St, London N1 9XW, England. (BioMed Central - www.biomedcentral.com/; BMC Public Health - www.biomedcentral.com/bmcpublichealth/)

Our news correspondents report that additional information may be obtained by contacting J. Malon, New England University, Center Excellence Neurosci, Biddeford, ME 04005, United States. Additional authors for this research include P. Shah, W.Y. Koh, G. Cattabriga, E. Li and L. Cao (see also Opioids - Prescription Opioids).

Keywords for this news article include: Biddeford, Maine, United States, North and Central America, Musculoskeletal Diseases and Conditions, Information Technology, Health and Medicine, Prescription Opioids, Risk and Prevention, Health Insurance, Public Health, Epidemiology, Chronic Pain, University of New England.